METHODS FOR ATTENUATING ATOPIC MARCH BY ADMINISTERING AN IL-4/IL-13 ANTAGONIST

Title:

METHODS FOR ATTENUATING ATOPIC MARCH BY ADMINISTERING AN IL-4/IL-13 ANTAGONIST

Document Type and Number:

WIPO Patent Application WO/2023/130010

Kind Code:

A8

Abstract:

Methods are provided for preventing the development of a new allergic condition or the worsening of an existing concomitant allergic condition in a subject having an atopic disease such as atopic dermatitis. In one aspect, the methods comprise administering to the subject a course of therapy of an IL-4/IL-13 antagonist, such as an anti-IL-4R antibody or antigen-binding fragment thereof.

More Like This:

WO/2017/024131	INSERTABLE VARIABLE FRAGMENTS OF ANTIBODIES AND MODIFIED A1-A2 DOMAINS OF NKG2D LIGANDS, AND NON-NATURAL NKG2D LIGANDS THAT BIND NON-NATURAL NKG2D RECEPTORS
WO/2013/129454	NOVEL ANTI-HUMAN IL-23 RECEPTOR ANTIBODY
JP2023115329	CYTOTOXICITY-INDUCING THERAPEUTIC AGENTS

Inventors:

GEBA GREGORY (US)
LI DATENG (US)
LI JUDY XIANG (US)

Application Number:

PCT/US2022/082535

Publication Date:

August 10, 2023

Filing Date:

December 29, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

REGENERON PHARMA (US)

International Classes:

C07K16/28; A61K39/395; A61P37/06

Attorney, Agent or Firm:

SMITH, Ryan, C. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: HYDRALAZINE COMPOSITIONS AND METHODS

Next Patent: DATA SYSTEM